Raymond James & Associates’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-104,485
Closed -$3.1M 4008
2023
Q4
$3.1M Sell
104,485
-63,093
-38% -$1.87M ﹤0.01% 1821
2023
Q3
$2.66M Buy
167,578
+150,652
+890% +$2.39M ﹤0.01% 1836
2023
Q2
$319K Sell
16,926
-28,482
-63% -$537K ﹤0.01% 3197
2023
Q1
$174K Buy
45,408
+5,658
+14% +$21.7K ﹤0.01% 3494
2022
Q4
$197K Sell
39,750
-170,987
-81% -$848K ﹤0.01% 3435
2022
Q3
$1.01M Sell
210,737
-20,137
-9% -$96.2K ﹤0.01% 2375
2022
Q2
$1.04M Sell
230,874
-11,066
-5% -$49.8K ﹤0.01% 2410
2022
Q1
$1.15M Sell
241,940
-11,932
-5% -$56.8K ﹤0.01% 2486
2021
Q4
$1.88M Sell
253,872
-5,395
-2% -$40K ﹤0.01% 2213
2021
Q3
$1.47M Sell
259,267
-3,571
-1% -$20.2K ﹤0.01% 2316
2021
Q2
$1.73M Sell
262,838
-5,951
-2% -$39.2K ﹤0.01% 2197
2021
Q1
$2.18M Sell
268,789
-2,219
-0.8% -$18K ﹤0.01% 1951
2020
Q4
$1.75M Sell
271,008
-19,449
-7% -$125K ﹤0.01% 1969
2020
Q3
$1.05M Sell
290,457
-22,850
-7% -$82.3K ﹤0.01% 2148
2020
Q2
$1.44M Buy
313,307
+16,081
+5% +$74K ﹤0.01% 1920
2020
Q1
$1.01M Sell
297,226
-236,863
-44% -$808K ﹤0.01% 1965
2019
Q4
$2.73M Sell
534,089
-49,346
-8% -$252K ﹤0.01% 1637
2019
Q3
$1.41M Sell
583,435
-10,591
-2% -$25.6K ﹤0.01% 1975
2019
Q2
$1.29M Sell
594,026
-25,297
-4% -$54.9K ﹤0.01% 2068
2019
Q1
$1.68M Buy
619,323
+23,774
+4% +$64.4K ﹤0.01% 1876
2018
Q4
$2.86M Sell
595,549
-53,284
-8% -$256K 0.01% 1422
2018
Q3
$6.14M Buy
648,833
+75
+0% +$710 0.01% 1099
2018
Q2
$6.31M Buy
648,758
+23,459
+4% +$228K 0.01% 1052
2018
Q1
$6.58M Buy
625,299
+5,942
+1% +$62.5K 0.01% 992
2017
Q4
$3.97M Buy
619,357
+161,603
+35% +$1.04M 0.01% 1255
2017
Q3
$3.5M Sell
457,754
-90,163
-16% -$690K 0.01% 1273
2017
Q2
$3.9M Sell
547,917
-80,319
-13% -$571K 0.01% 1153
2017
Q1
$2.43M Sell
628,236
-13,924
-2% -$53.9K 0.01% 1414
2016
Q4
$1.31M Sell
642,160
-15,042
-2% -$30.7K ﹤0.01% 1772
2016
Q3
$1.76M Buy
657,202
+10,762
+2% +$28.8K ﹤0.01% 1539
2016
Q2
$1.99M Buy
646,440
+19,016
+3% +$58.6K 0.01% 1333
2016
Q1
$5.35M Buy
627,424
+12,063
+2% +$103K 0.02% 787
2015
Q4
$8.35M Buy
615,361
+21,990
+4% +$298K 0.03% 592
2015
Q3
$5.7M Buy
593,371
+29,856
+5% +$287K 0.02% 678
2015
Q2
$8.1M Buy
563,515
+50,444
+10% +$725K 0.03% 598
2015
Q1
$4.59M Buy
513,071
+99,093
+24% +$887K 0.02% 785
2014
Q4
$2.53M Buy
413,978
+124,745
+43% +$761K 0.01% 1027
2014
Q3
$3.06M Buy
289,233
+28,078
+11% +$297K 0.02% 866
2014
Q2
$3.1M Buy
261,155
+38,916
+18% +$461K 0.02% 859
2014
Q1
$3.32M Buy
222,239
+29,314
+15% +$438K 0.02% 753
2013
Q4
$2.83M Buy
192,925
+27,912
+17% +$409K 0.02% 780
2013
Q3
$2.81M Buy
165,013
+18,517
+13% +$315K 0.02% 714
2013
Q2
$2.43M Buy
+146,496
New +$2.43M 0.02% 712